Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Invivyd, Inc.
  6. Financials
    IVVD   US00534A1025

INVIVYD, INC.

(IVVD)
  Report
Delayed Nasdaq  -  04:00 2022-09-23 pm EDT
2.970 USD   -9.17%
09/13INVIVYD, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
09/13Invivyd, Inc. has Changed its Ticker to IVVD from ADGI
CI
09/13Adagio Therapeutics, Inc. has Changed its Name to Invivyd, Inc
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2021 2022 2023 2024
Capitalization1 808323--
Enterprise Value (EV)1 216-57,7148246
P/E ratio -1,36x-1,24x-1,50x-2,15x
Yield ----
Capitalization / Revenue --31,6x2,37x
EV / Revenue --14,5x1,80x
EV / EBITDA -0,95x0,27x-0,71x-2,67x
Price to Book 1,45x0,97x2,58x10,2x
Nbr of stocks (in thousands) 111 252108 831--
Reference price (USD) 7,262,972,972,97
Announcement Date 03/30/2022---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2021 2022 2023 2024
Net sales1 --10,2136
EBITDA1 -227-215-210-91,9
Operating profit (EBIT)1 -227-251-229-146
Operating Margin ---2 237%-107%
Pre-Tax Profit (EBT)1 -227-262-234-170
Net income1 -227-262-234-160
Net margin ---2 286%-117%
EPS2 -5,32-2,40-1,98-1,38
Dividend per Share ----
Announcement Date 03/30/2022---
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 ------
EBITDA ------
Operating profit (EBIT)1 -60,4-83,1-101-51,7-54,1-56,4
Operating Margin ------
Pre-Tax Profit (EBT)1 -60,4-83,0-101-51,0-53,9-56,2
Net income1 -60,4-83,0-101-51,0-53,9-56,2
Net margin ------
EPS2 -0,98--0,93-0,47-0,49-0,52
Dividend per Share ------
Announcement Date 11/15/202103/30/202205/13/202208/15/2022--
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2021 2022 2023 2024
Net Debt1 ----
Net Cash position1 59138117577,6
Leverage (Debt / EBITDA) 2,61x1,77x0,83x0,84x
Free Cash Flow ----
ROE (Net Profit / Equities) -81,8%-46,6%-87,6%-111%
Shareholders' equity1 277563267143
ROA (Net Profit / Asset) ----
Assets1 ----
Book Value Per Share2 5,023,051,150,29
Cash Flow per Share ----
Capex ----
Capex / Sales ----
Announcement Date 03/30/2022---
1 USD in Million
2 USD
Estimates
Key data
Capitalization (USD) 323 226 659
Number of employees 102
Free-Float 66,6%
Free-Float capitalization (USD) 215 277 389
Avg. Exchange 20 sessions (USD) 1 638 020
Average Daily Capital Traded 0,51%
EPS & Dividend